Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Accenture
Chinese Patent Office
Baxter
Colorcon
Covington
McKesson
Julphar
Mallinckrodt

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,800,807

« Back to Dashboard

Which drugs does patent 5,800,807 protect, and when does it expire?

Patent 5,800,807 protects LOTEMAX and is included in one NDA.

This patent has twelve patent family members in ten countries.
Summary for Patent: 5,800,807
Title: Ophthalmic compositions including glycerin and propylene glycol
Abstract:There are disclosed ophthalmic compositions having high water-binding properties which are useful as: moisturizing and lubricating (i.e. artificial tear) solutions, dry eye therapies, contact lens wetting and lubricating solutions, and as delivery vehicles for ophthalmic drugs. The subject compositions include glycerin in combination with propylene glycol. The subject compositions may further include cellulose derivatives, e.g. hydroxypropyl methyl cellulose, along with preservatives, e.g. benzylalkonium chloride, PHMB, sorbic acid, etc. Preferred compositions have at least 11% bound water, a pH from about 7.1 to 7.5, and an osmolality between about 280 to about 320 mOsm/Kg.
Inventor(s): Hu; Zhenze (Pittsford, NY), Denick; John (Pittsford, NY)
Assignee: Bausch & Lomb Incorporated (Rochester, NY)
Application Number:08/794,690
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use;

Drugs Protected by US Patent 5,800,807

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bausch And Lomb Inc LOTEMAX loteprednol etabonate GEL;OPHTHALMIC 202872-001 Sep 28, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,800,807

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 6253398 ➤ Subscribe
Australia 723024 ➤ Subscribe
Brazil 9807117 ➤ Subscribe
Canada 2278802 ➤ Subscribe
Germany 69817788 ➤ Subscribe
European Patent Office 0969812 ➤ Subscribe
Spain 2205449 ➤ Subscribe
Hong Kong 1026363 ➤ Subscribe
Japan 2001511135 ➤ Subscribe
South Korea 100472132 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Chubb
Merck
AstraZeneca
Colorcon
McKesson
Queensland Health
Moodys
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot